@article{80725064e1cb4f54b6fbaec763cde3d0,
title = "In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020",
author = "Liu, {Yuag Meng} and Ko, {Wen Chien} and Ho, {Mao Wang} and Lee, {Yu Lin} and Hsueh, {Po Ren}",
note = "Funding Information: Investigators associated with the SMART Taiwan Group in 2020: Po-Ren Hsueh (China Medical University Hospital, Taichung, Taiwan), Wen-Chien Ko (National Cheng Kung University Hospital, Tainan, Taiwan), Po-Liang Lu (Kaohsiung Medical University Hospital, Kaohsiung, Taiwan), Chun-Eng Liu (Changhua Christian Hospital, Changhua, Taiwan), Hung-Jen Tang (Chi-Mei Medical Centre, Tainan, Taiwan), Fu-Der Wang (Taipei Veterans General Hospital, Taipei, Taiwan), Yao-Shen Chen (Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan), Shih-Ming Tsao (Chung Shan Medical University Hospital, Taichung, Taiwan), and Mao-Wang Ho (China Medical University Hospital, Taichung, Taiwan). Funding Information: This study was supported by Merck & Co., Inc. (Rahway, NJ, USA) ",
year = "2023",
month = jan,
doi = "10.1016/j.jinf.2022.10.038",
language = "English",
volume = "86",
pages = "66--117",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "W.B. Saunders Ltd",
number = "1",
}